The world was 100% more prepared for COVID-19 than it was for the flu 100 years ago, Dr. David Pride says.

From dexamethasone, remdesivir to monoclonal antibodies and convalescent plasma, we look at the various coronavirus therapies being used in Canada.

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.

The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

A Calgary family is mourning the death of their father after he was diagnosed with COVID-19 while being treated at the Foothills hospital. The family is fighting for his daughter, who also tested positive, to have access to remdesivir.

The antiviral drug, which was recently used to treat U.S. President Donald Trump, also appeared to reduce the risk of death in some patients.

Here's a look at what we know and what we don't know so far.

How intensive care physicians treat critically ill COVID-19 patients has come a long way since Canada treated its first patient in hospital last January.

Health Canada has authorized the use of the drug remdesivir to treat people with severe COVID-19 symptoms.